Hin Sang Group (International) Holding Co. Ltd. (6893) AI Stock Analysis

• Market Cap: HK$305.70M
• Dividend Yield: N/A
• Average Volume (3M): 146.87K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.30
• Revenue Growth: 10.42%
• EPS Growth: 11.14%
• Country: HK
• Employees: 230
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): >-0.01
• Shares Outstanding: 1,091,796,000
• 10 Day Avg. Volume: 47,000
• 30 Day Avg. Volume: 146,866
• PEG Ratio: -0.13
• Price to Book (P/B): 1.46
• Price to Sales (P/S): 2.47
• P/FCF Ratio: -53.15
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 49 Neutral
• Price Target: HK$0.26 ▼(-13.67% Downside)

The overall stock score is primarily impacted by the company's weak financial performance, characterized by ongoing losses and high leverage. While technical analysis shows positive momentum, the overbought indicators suggest caution. The negative P/E ratio and lack of dividend yield further weigh on the valuation score.

Positive Factors

Diversified Revenue Model

A diversified revenue model through multiple channels reduces dependency on any single source, enhancing resilience against market fluctuations.

Premium Pricing Strategy

Premium pricing can lead to higher profit margins, supporting long-term profitability if the brand maintains its perceived value.

Market Position in Health Sector

Positioning in the growing health and wellness sector aligns with increasing consumer focus on health, supporting long-term demand.

Negative Factors

High Leverage

High leverage can strain financial resources and limit flexibility, posing risks to long-term financial health and stability.

Negative Cash Flow

Negative cash flow indicates insufficient cash generation to cover losses, challenging the company's ability to sustain operations without external financing.

Ongoing Losses

Persistent losses and negative margins highlight operational inefficiencies, threatening long-term viability unless addressed.

Hin Sang Group (International) Holding Co. Ltd. Business Overview & Revenue Model

Company Description

Hin Sang Group (International) Holding Co. Ltd., together with its subsidiaries, primarily engages in the manufacture, marketing, and sale of healthcare products primarily targeting at children in Hong Kong and Mainland China. The company operates through four segments: Product Development, Brand Development and Management, Trading of Goods, and Healthcare. The Product Development segment develops and sells personal care products, household products, and health supplements under the Hin Sang, Tai Wo Tong, Cheers Smart, Care Plus, Shuang Long, and King's Antiseptic brand names. The Brand Development and Management segment engages in marketing, selling and distribution, logistics, and delivery services of personal care products under the Pahmi, Enear, Vcnic, Zici, and Sunew brand names; and manages and develops brands for its brand proprietors. The Trading of Goods segment engages in the distribution and sale of skin care products, personal care products, and household products purchased from various authorized dealers, independent traders, manufacturers, parallel importers, and suppliers. The Healthcare segment provides Chinese medical healthcare related services for mothers and children; develops mother and child related health products; and hospital, medical center, and related services. It is also involved in the trading of skin care, personal care, and slimming products; and property holding business. The company sells its products in Hong Kong, as well as sells through a network of distributors in the People's Republic of China and Macau. It also sells its products online. The company was founded in 1996 and is headquartered in Tsim Sha Tsui, Hong Kong. Hin Sang Group (International) Holding Co. Ltd. is a subsidiary of Genwealth Group Holding Company Limited.

How the Company Makes Money

The company generates revenue through multiple streams, including direct sales of its health food products across various retail channels, online sales through e-commerce platforms, and wholesale distribution to other retailers and businesses. Hin Sang Group also capitalizes on strategic partnerships with suppliers and distributors to enhance its market reach and product offerings. Additionally, the company may benefit from brand recognition and customer loyalty in the health and wellness sector, contributing to its overall earnings.

Hin Sang Group (International) Holding Co. Ltd. Financial Statement Overview

Summary

Hin Sang Group faces significant financial challenges, with ongoing losses and high leverage. Despite some revenue growth, profitability and cash flow management remain critical issues. The company needs to focus on improving operational efficiency and reducing debt to enhance financial stability.

Income Statement

Hin Sang Group has shown some revenue growth, but profitability remains a significant concern. The gross profit margin is relatively healthy, but the company has been consistently operating at a net loss, with negative EBIT and EBITDA margins. This indicates challenges in managing operational costs and achieving profitability.

Balance Sheet

The company's balance sheet reveals high leverage, with a debt-to-equity ratio above 2, indicating potential financial risk. The return on equity is negative, reflecting ongoing losses. However, the equity ratio is moderate, suggesting some stability in asset financing.

Cash Flow

Cash flow analysis shows negative free cash flow growth and a low operating cash flow to net income ratio, highlighting cash management issues. The free cash flow to net income ratio is significantly negative, indicating that the company is not generating sufficient cash from its operations to cover its losses.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	91.89M	91.89M	92.62M	81.46M	120.55M	119.44M
Gross Profit	60.28M	60.28M	57.41M	38.84M	69.08M	68.79M
EBITDA	-22.51M	-16.57M	-3.58M	-17.05M	21.82M	-4.35M
Net Income	-49.36M	-49.36M	-36.70M	-49.49M	-11.91M	-31.95M
Balance Sheet
Total Assets	555.73M	555.73M	587.85M	618.28M	693.77M	711.82M
Cash, Cash Equivalents and Short-Term Investments	19.87M	19.87M	19.35M	12.44M	17.58M	18.05M
Total Debt	344.41M	344.41M	321.10M	318.42M	320.91M	345.50M
Total Liabilities	399.61M	399.61M	378.52M	378.37M	391.97M	392.24M
Stockholders Equity	155.28M	155.28M	208.84M	239.38M	301.59M	318.28M
Cash Flow
Free Cash Flow	-4.27M	-4.27M	5.62M	-3.79M	23.65M	-53.16M
Operating Cash Flow	638.00K	638.00K	6.29M	402.00K	23.99M	10.65M
Investing Cash Flow	-4.73M	-4.73M	-585.00K	-2.09M	15.20M	-63.72M
Financing Cash Flow	6.27M	6.27M	-4.87M	-93.00K	-41.67M	55.34M

Hin Sang Group (International) Holding Co. Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.30
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:6893, the sentiment is Positive. The current price of 0.3 is above the 20-day moving average (MA) of 0.28, above the 50-day MA of 0.25, and above the 200-day MA of 0.21, indicating a bullish trend. The MACD of <0.01 indicates Positive momentum. The RSI at 54.32 is Neutral, neither overbought nor oversold. The STOCH value of 72.48 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:6893.

Hin Sang Group (International) Holding Co. Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1455	70 Outperform	HK$290.23M	12.34	5.51%	6.41%	-34.28%	-45.72%
2023	66 Neutral	HK$368.85M	6.48	10.92%	―	11.10%	-4.38%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
3332	62 Neutral	HK$664.25M	21.93	3.92%	―	-0.92%	-71.88%
1962	60 Neutral	HK$317.91M	10.59	3.77%	10.32%	-6.67%	-29.55%
6893	49 Neutral	HK$305.70M	-7.63	-23.55%	―	10.42%	11.14%

Hin Sang Group (International) Holding Co. Ltd. Corporate Events

Hin Sang Group Reports Improved Financial Performance Despite Losses

Hin Sang Group (International) Holding Co. Ltd. reported its interim results for the six months ended 30 September 2025, showing a revenue increase of 7.9% to HK$49,857,000 and a gross profit rise of 13.3% to HK$34,004,000 compared to the same period in 2024. Despite these improvements, the company recorded a loss of HK$9,841,000, which is a 48.9% reduction in loss compared to the previous year, indicating a positive trend in financial performance.

The most recent analyst rating on (HK:6893) stock is a Hold with a HK$0.22 price target. To see the full list of analyst forecasts on Hin Sang Group (International) Holding Co. Ltd. stock, see the HK:6893 Stock Forecast page.

Hin Sang Group Projects Significant Reduction in Net Loss

Hin Sang Group (International) Holding Co. Ltd. announced an expected decrease in its consolidated net loss by over 47% for the six months ended 30 September 2025, compared to the same period in 2024. This improvement is attributed to increased gross profit due to enhanced cost containment measures and a reduction in administrative and operating expenses, including staff costs and legal fees. The final unaudited results are pending and will be released on 27 November 2025, with stakeholders advised to exercise caution.

The most recent analyst rating on (HK:6893) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Hin Sang Group (International) Holding Co. Ltd. stock, see the HK:6893 Stock Forecast page.

Hin Sang Group Schedules Board Meeting for Interim Results Review

Hin Sang Group (International) Holding Co. Ltd. has announced that its board of directors will convene on November 27, 2025, to review and approve the company’s unaudited interim results for the six months ending September 30, 2025. The meeting will also consider the possibility of declaring an interim dividend. This announcement is part of the company’s compliance with the listing rules of the Hong Kong Stock Exchange.

The most recent analyst rating on (HK:6893) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Hin Sang Group (International) Holding Co. Ltd. stock, see the HK:6893 Stock Forecast page.